SCIFLUOR LIFE SCIENCES LLC has a total of 19 patent applications. Its first patent ever was published in 2013. It filed its patents most often in WIPO (World Intellectual Property Organization), China and Canada. Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and medical technology are FURIEX PHARMACEUTICALS INC, GUANGZHOU BOJI MEDICAL BIOTECHNOLOGY CO LTD and PRISM PHARMA CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 4 | |
#2 | China | 3 | |
#3 | Canada | 2 | |
#4 | Hong Kong | 2 | |
#5 | Japan | 2 | |
#6 | Republic of Korea | 2 | |
#7 | United States | 2 | |
#8 | EPO (European Patent Office) | 1 | |
#9 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals | |
#3 | Medical technology |
# | Name | Total Patents |
---|---|---|
#1 | Duggan Mark E | 17 |
#2 | Furuya Takeru | 14 |
#3 | Purohit Ajay | 8 |
#4 | Edwards Scott D | 7 |
#5 | Edwards D Scott | 6 |
#6 | Askew Ben C | 5 |
#7 | Heidebrecht Richard W | 5 |
#8 | Furuya Yakeru | 3 |
#9 | Edward D Scott | 3 |
#10 | Furuya Ken | 2 |
Publication | Filing date | Title |
---|---|---|
US2014221410A1 | Fluorinated 3-(2-oxo-3-(3-arylpropyl)imidazolidin-1-yl)-3-arylpropanoic acid derivatives | |
KR20150115812A | Fluorinated integrin antagonists | |
WO2013151719A2 | Fluorinated oxazolidinone derivatives | |
CA2870095A1 | Fluorinated 2-amino-4-(benzylamino)phenylcarbamate derivatives |